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Synaptosomes isolated from the adult rat hippocclmptls ¢onlain the =, and//.subsp~i~ of protein kinas~ C (PKC}, but not the psubsl~¢ies which 
is abundan|iy expressed in the pyramidal cells in this brain region. AIIhough the ~'-suhspe¢ies is known to respond signillcantly to ff¢¢ araehidonic 
acid. it Is feund that both the =. and/~.sub~',p~cies are also activated drurnatically by arachidonic acid in synerllistic action with diacylglyeerol, 
Oleic, liaolelc, and IInolcnic acids are all active. It is possible that unsaturated fatty acids may take part in the activation of =. and #.subspecies 
of PKC which are present in the prc~ynaptic nerve endings termin~,ling at the hippocampa| pyramidal cells. 
Protein kinas¢ C', Ar~chtdonic i~,eid 
I. INTRODUCTION 
The activation of protein kinase C (PKC) has been 
proposed to play key roles in maintenance of long-term 
potentiation (LTP) in the hippocampus (for reviews, 
see [1-4]). Growth-associated protein (GAP43, Fl, 
BS0, neuromodulin) has been known to be one of the 
major target proteins of PKC which is associated with 
presynaptic nerve endings [5,6]. Although the 
biological function of this protein ~s not identified, its 
phosphorylation by PKC is implicated in the control of 
diverse synoptic processes, including transmitter release 
[7], calmodulin sequestration [8], neuronal develop- 
ment and regeneration [9-12] It has been suggested, on 
the other hand, that unsaturated free fatty acids (FFAs) 
such as arachidonic and oleic acids may play a role in 
maintenance of LTP, particularly at the presynaptic 
portion of the hippocampus [13], To explain this poten- 
tial role of FFAs, the possibility has been discussed that 
FFAs activate PKC directly [13-19]. The ~'subspecies, 
in fact, shows properties that respond to FFAs to ex- 
hibit enzymatic activity [16,20,21]. Electron- 
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microscopic analysis with specific antibodies, however, 
has shown that the -t-subspecies is not present in the 
nerve endings which terminate at the adult rat hip- 
pocarnpal pyramidal cells, although these cells express a 
large quantity of this PKC subspecies [22,23]. 
The biochemical studies described herein confirm 
that synaptosomes i olated from the adult rat hip- 
pocarnpus contain the ix- and/3- but not 3,-subspecies, 
and that these PKC subspecies present in the synap- 
tosomes arc activated ramatically by synergistic action 
of an unsaturated FFA and diacylglycerol (DAG). 
2. MATERIALS AND METHODS 
2.1. Synaptosomea 
Spraque-Dawley rats (6-8 weeks)were used The cerebrum and 
hipp0campus regions were dissected, and synaptosomes were 
prepared using the Percotl 8radient method described by Dunkley et 
al, [24]. 
2.2. Analysis of PKC subspecies 
Synaptosomes were lysed in 20 mM Tris-HCl, pH 7.5, containing 
10 ram EGTA, 2 mM EDTA, 1 mM dithiothreitol, I mM 
phenylmethylsulphonyl fluoride and 45 /zM leupeptin, followed by 
sonication for 2 x 15 s, and staining on ice for 20 rain. Then, an equal 
volume of the above solution containing, in addition, 2% (v/v) Triton 
X-100 was added, and the mixture was sonicated again for 2 x 15 s 
and incubated for additional 20 rain at 4°C with stirring to solubilize 
membrane.bound PKC as much as possible, Following centrifugation 
for 60rain at 100 000 x ,g, the soluble fraction was subjected to PKC 
subspecies analysis upon hydroxyapatite chromatography as describ. 
ed [25]. The enzyme subspecies in the cerebrum and hippocampus 
regions were analyzed under the same conditions except hat these 
tissues were homogenized in 10 volumes of the buffer with a Teflon. 
glass homogemzer. 
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2.L PKC subxpcciex mut it~ o~say 
T!te n., #'- and .1.Subspecte~ of PKC employed were purified ['tom 
the rat brain ~,olubl¢ fraction as des¢rtbed []6), altd all preparatton~ 
were pros:stonily pure, The en~ym¢ aellvity was a~saycd wills calf 
thymus H I hlstone a~ phosphate acceplor, 3'he reaction mL~tlure {0.25 
mi) contained 20 mM Trls-HCi (pH ?,S), 10 mM ,MtiCl=, 10 ~M 
[-t;uP}ATP (2000 ¢pmtnmol), 10 ~ M CaCI=, 100~il Hi hisloa¢, en- 
zyme, PS, DAO and FF^ as indicted In each ¢.spcrlmenl. PN and 
DAG were mixed firsl In chloroform, and dried under tt nitroilen 
stream, The residue was then sonlcated in a buffer s0hllion to prepare 
i pid vesic es as described [l  I ], FFA normally dissolved in ethanol was 
directly added to the reaction mixtu:re. Neither the order of addition 
of these lipkls nor |he prior mixing of FPA wlll~ PS/DAG arrested 
significantly the reaction velocity, The reaction was started by the ad, 
dillon of enzyme. After [ncubatio~ for 3 rain at .tO*C, the acid. 
precipitable radioactivity was determined as described [26]. One unit 
of PKC was defined as that amounl of emtyln¢ which incorporated 
one nmol or phosphate from ATP into histone under the assay condi. 
l ions. 
2,4, /#rm~tnoblol anulysis 
Antibodies that recognize specifically e~ach PKC subspecies were 
prepared, and Immunoblot analysis was carried Otis aS described [26]. 
2,5. Chemicals 
All chemicals were of analytical tirade, [-rJ:PJATP was a product 
of Ne~t England Nuclear. Calf thynlus HI h s one was prepared as 
described [27], PS, DAGs and FFAs were obtained from Serdary 
Research Laboratories. 
3. RESULTS 
3, 1 PKC subspecies in hippocampal synaptosomes 
Biochemical analysis with a hydroxyapatite column 
revealed that the rat hippocampus contained a large 
quantity of the -~-subspeciesin addition to the o~- and/3- 
subspecies (Fig, 1 A). The synaptosomes prepared from 
this brain region, however, contained a little or no 3'- 
subspecies (Fig. I B). These findings are consistent with 
those obtained by electron-microscopic analysis with 
specific antibodies [22,23]. The c~-and /3-subspecies 
were expressed both in synaptosomes (nerve endings) 
and in post-synaptic pyramidal cells [22]. The whole 
cerebrum and synaptosomes isolated therefrom con- 
tained the three PKC subspecies (Figs; IC and ID). 
These subspecies were all identified by immunoblot 
analysis with specific antibodies. 
3,2, Synergistic action of arachidonic acid and DAG 
Although arachidonic acid and Can+ could activate 
significantly the 3'- but not t~- and /3-subspecies, both 
the t~- and ~-, particularly c~-subspecies, were found to 
• respond highly to arachidonic acid in the presence of 
DAG and Ca :+ (10 -~ M) to exhibit an enzymatic ac- 
tivity nearly equivalent o that obtained in the presence 
of PS and DAG (Fig, 2 and Table I). It did not appear, 
however, that arachidonic acid exerted this effect simp- 
ly be being substituted for PS. The maximum activity 
was obtained at approximately 50/~M arachidonic acid 
(Fig. 3)i 
3.3. Specificity of fatty acid 
The synergistic action of fatty acid and DAG was 
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Fig. I. Chromatographic profiles of PKC subspecies in rat brain 
tissues and synaptosomeL The:detailed experimental conditions to 
isolate and identify rise PKC subspecies are described in section 2, w, 
B and -~: tile ¢t., B. and -r,subspectes of PKC, respectively. (A) PKC 
subspecies from the aduh rat htppocampus tissue; (B) PKC subspecies 
in the synaplosomes rrom the adult rat hippocampus: (C) PKC 
subspecies from the adult rat cerebrum; and (D)PKC subspecies in 
the synaptosomes from the adult rat cerbrum. (*--*) assayed with 
l0 "a M Ca =*' , 8 pg/m] PS and 0.8 ~4g/ml DAG; and (o--o] assayed 
with EGTA (0.5 raM) instead of Ca a ",P$ attd DAG. 
: i 
observed not only with arachidonic acid but also with 
other unsaturated FFAs such as  oleic, linoleic and 
[inolenic acids (Table I), Lonolenic acid was less active 
for the/3- and ~,-subspecies at 10, 4 M Ca '+. In the 
absence of DAG, unsaturated FFAs activated the ,y- 
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Fig, 2, Activation of PKC subspecies by arachldonic acid in the 
presence of ')arious Concentrations of DAG. The enzyme activity was 
assayed under the standard conditions with 50 ~.M arachidonic acid 
and diolcin as indicated. (A) the a-subspecies; (B) the ~-subspecies; 
and (C) the ~.subspecies. (,-- ,)  assayed with Ca 2 + and arachidonic 
acid; (o--o) assayed with arachidonic aid; and ( t~ - - '~  assayed with 
Ca z + 
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~tlmulatlon olr PKC ~,tlvitlt by un)murmcd ['mty .~lds, 
Ea¢it PKC )lib( [~ct¢'; wa'~ tt,~t~tyfd t)ndcr the ~lztntl~rd ¢ondt|iofl~t lo list pr¢,i,n¢~ of 0.11 i, ll.tmt diol¢ln trod SO #,Nt FFA its Indicilted. Numbcr~ 
~hOw the ~ld.prc~ipltz~blc radio~;tivll~ (¢pm}, ~nd ihow in pnremhcses ~how p~r¢~nl~*il~t or tlla[ obt~tiled in that pro~n¢¢ or io ° '  M C~ICI:, II 
~tJimt P~ ~nd o.II ~i l fml diol¢ln ~s I00%, 
= rr.$ubs r~¢I¢~' ~.$~bspc-cics ' -~,$ubspt~let ' 
* DA~ = DA¢~ * DA¢~ = DAG * DA~3 - DAG 
PS 29 ItltO 2'/2110 32 I J0 
(|00) (lO0) film) 
None $40 Ii90 ¢~0 II00 I 710 I II0 
(~l (3) (3) (4} iS) (]) 
Olelc acld 26 :VI0 3130 19 370 6'/30 26 460 l0 170 
(85) (I0) (?I) (:IS) (~i;!) (63) 
kinoleic ncld 23 120 2"/0¢I I0 480 4330 2S 230 13 800 
O1) (9) (38) (16) O8) (43) 
LinolcBic Itcid l'~ t.)20 24~(~ $ 420 3SSO "/43(3 '/520 
(fi0) (8) (~,0) (13) (23) (23) 
Arachidonlc ncld 14 330 2670 14 270 4663 16 10(3 8 280 
(48) (9) (S2) (l'/) (S0) (26) 
subspecies most efficiently. Saturated FFAs. palmitic 
and stearic acids, were practically inactive for all en.. 
zyme Subspecies. 
4. DISCUSSION 
Routtenberg and co.workers [13] have proposed that 
oleic acid may be involved in the maintenance of LTP 
by activating PKC Bliss and collaborators [28] have 
postulated a possible role for arachidonic acid as a 
retrograde messenger from the postsynaptic to the 
presynaptic portion to maintain LTP. Although the 
i 121 A 
; . 
0 SO 109 
B 
?, 
i i 
50 109 0 50 100 
Arachidonic Acid (~M) 
C 
Fig, 3. Activation of PKC subspecies by DAG in the presence of 
various concentrations of arachidonic acid. The enzyme activity was 
assayed under the standard conditions with 0.8 #g/ml dioleln and 
arachidonic acid as indicated. (A) the <x.subspecies; (B) the B- 
subspecies; and (C) the -/-subspecies, (*--*) assayed with diolein; and 
(o--o) assayed without diolein, 
biochemical mechanism of developing LTP and th. 
precise role of PKC in synaptic transmission have not 
yet been clarified, on~ of the puzzles resulting from 
immuno-cytochemical studies i.¢ that the ~.subspecies of 
PKC, which is most sensitive to unsaturated FFAs for 
its activation, is localized in the postsynaptic portion 
but not in the presynaptic nerve endings, at [east in the 
adult rat hippocampus [22]. The biochemical analysis 
described above supports this uneven distribution of the 
• y.subspecies in the hippocampal pre- and postsynaptic 
portions, and further shows that the ¢x- and B, 
subspecies, which are clearly present in the presynaptic 
portion, respond to unsaturated FFAs such as 
arachidonic and oleic acids in the presence of a small 
quantity of DAG. 
Verkest eta[. [7] have described that the mixture of 
PKC subspecies obtained from the rat brain and from 
the bovine spleen is greatly activated by the 
simultaneous addition of oleic acid and DAG. Seifert et 
al. [18] and Touny et al. [19] have subsequently 
reported that some unsaturated FFAs and DAG 
synergistically activate platelet PKC, although platelets 
contain another structurally unknown, FFA.sensitive 
type of PKC [29]. Seifert et al. [30] and Szamel et al. 
[31] have described some evidence suggesting that un- 
saturated FFAs may have potentials to enhance the ac- 
tivation of human platelets and lymphocytes, respec- 
tively, presumably through the PKC signal pathway. It 
is possible that these obervations made by these 
previous authors are related to those described in the 
present report. 
Such synergistic action of unsaturated FFAs and 
DAG on the PKC activation appears to imply a poten- 
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tlal role of FFAs in ehe activation or PKC, par=icularly 
It~ c~.subspe¢les universally present in all tissues and cell 
types, it ha~ been recently +hewn thal pho+pholipase A= 
is indeed activated in a signal.dependent manner to pro- 
duce unsaturated FFAs [32J, More recently, Felder et 
al, [33] have demonstrated the release of' arachidoni¢ 
acid in the hippoc~mpal neuron by activaUon of' 
phospholipase Az with serotonin, Then, i¢ is attractive 
to mzrmise zhat several phosphollpases may be involved 
in the regulationofcel[ functions, and that activation of 
the PKC family is integrated into the degradation 
cascade of' various membrane phospholipids which is 
elicited by extracellular signals. 
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